300147 ST香雪製藥
按盤價 
9.780 -0.100 (-1.012%)
9.780 -0.100 (-1.012%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,145,913 | -25.28% | 1,858,662 | 2,299,288 | 2,187,070 | 2,970,576 | |
| 減：營業總成本 | 1,413,592 | -18.38% | 2,266,742 | 2,452,474 | 2,575,669 | 3,167,436 | |
| 其中:營業成本 | 784,032 | -25.80% | 1,405,807 | 1,509,521 | 1,643,173 | 2,189,989 | |
| 財務費用 | 203,510 | 12.59% | 231,011 | 241,471 | 212,510 | 202,750 | |
| 資產減值損失 | (25,693) | 1,620.76% | (380,109) | (163,342) | (138,578) | (482,077) | |
| 公允價值變動收益 | 630 | -574.45% | 636 | 2,728 | (12) | 15,641 | |
| 投資收益 | 452 | -96.93% | (6,000) | (50,640) | 47,329 | 33,589 | |
| 其中：對聯營企業和合營企業的投資收益 | (511) | 20.22% | (1,343) | (52,159) | 903 | (19,543) | |
| 營業利潤 | (277,173) | 77.35% | (784,525) | (332,716) | (464,142) | (575,277) | |
| 利潤總額 | (335,222) | 78.46% | (842,071) | (388,951) | (511,864) | (622,344) | |
| 減：所得稅費用 | 3,866 | -57.29% | 19,154 | 12,795 | (7,215) | 24,458 | |
| 淨利潤 | (339,088) | 72.22% | (861,224) | (401,746) | (504,648) | (646,801) | |
| 減：非控股權益 | 22,814 | 9.11% | (2,664) | (12,782) | 25,410 | 29,772 | |
| 股東淨利潤 | (361,902) | 66.16% | (858,560) | (388,964) | (530,058) | (676,573) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.550 | 66.67% | -1.300 | -0.590 | -0.800 | -1.020 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 1.047 | -59.42% | 1.595 | 2.911 | 3.637 | 4.454 | |
| 審計意見 # | -- | 标准的无保留意见 | 保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 18/11/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
